Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Orchid BioSciences, Inc ORCH -- Ignore unavailable to you. Want to Upgrade?

To: rich987 who wrote (63)	11/25/2003 1:05:37 AM
From: Skywatcher	Respond to of 94

It's PATHETIC!!!!..... I don'e know what to make of it, other than a constant dribble of money OUT of my pocket...the only saving grace is that I only have 1/2 left and bought it a long time ago for .40 or something. I really had some hope that the DNA thing would be MUCH bigger by this point.... CC

To: rich987 who wrote (63)	11/25/2003 10:06:31 AM
From: Skywatcher	Respond to of 94

and then!!!! we get a hit on ORCH Orchid Cellmark Awarded FBI Contracts to Develop SNP Technology for Advanced Forensic Applications Tuesday November 25, 7:00 am ET PRINCETON, N.J., Nov. 25 /PRNewswire-FirstCall/ -- Orchid BioSciences, Inc. (Nasdaq: ORCH - News) today announced that its Orchid Cellmark unit was awarded two contracts from the U.S. Federal Bureau of Investigation to develop specific aspects of the Company's SNP technology for additional forensic DNA testing applications. The goal of the two contracts is to develop new forensic tools that will increase the ability of investigators to identify individuals using DNA samples that have degraded and therefore contain a limited amount of genetic material. Work on both of these contracts is being undertaken in Orchid Cellmark's Dallas facility and is expected to be completed in about one year. CC